MarketCap
Facebook
X
Telegram
Covetrus Net Income | CVET
Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.
Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.[1]
It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.
The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.
Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.
It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.
However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.
Annual Net Income Covetrus
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -54 M | -19 M | -980 M | 101 M | 64 M | 70.3 M | 60.3 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 101 M | -980 M | -108 M |
Quarterly Net Income Covetrus
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -4 M | -2 M | - | -4 M | -31 M | -16 M | -4 M | -35 M | 54 M | -33 M | -37 M | -906 M | -10 M | -13 M | 33 M | 16 M | 29 M | 23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 54 M | -906 M | -55.3 M |
References
- Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.
Net Income of other stocks in the Health information services industry
| Issuer | Net Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akerna Corp.
KERN
|
-153 M | - | - | $ 161 M |  USA |
 |
Accolade
ACCD
|
-99.8 M | - | 0.29 % | $ 206 M | USA |
 |
Computer Programs and Systems
CPSI
|
4.35 M | - | 4.4 % | $ 133 M | USA |
 |
Castlight Health, Inc.
CSLT
|
-62.2 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
70.1 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
22.6 M | - | - | $ 6.37 B | USA |
 |
Cerner Corporation
CERN
|
556 M | - | - | $ 27.9 B | USA |
 |
Change Healthcare
CHNG
|
-57.4 M | - | - | $ 9.03 B | USA |
 |
iCAD
ICAD
|
-5.62 M | - | - | $ 102 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
-292 M | - | -10.39 % | $ 886 M | USA |
 |
OptimizeRx Corporation
OPRX
|
5.13 M | $ 7.71 | 0.74 % | $ 143 M | USA |
 |
R1 RCM
RCM
|
97.2 M | - | - | $ 3.81 B | USA |
 |
GoodRx Holdings
GDRX
|
30.4 M | $ 3.45 | 0.56 % | $ 1.23 B | USA |
 |
Signify Health
SGFY
|
-577 M | - | -0.02 % | $ 7.21 B | USA |
 |
MTBC
MTBC
|
10.8 K | - | -0.58 % | $ 51.7 M | USA |
 |
Progyny
PGNY
|
58.5 M | $ 25.65 | 0.15 % | $ 2.19 B | USA |
 |
Phreesia
PHR
|
2.31 M | $ 12.12 | 1.17 % | $ 724 M | USA |
 |
1Life Healthcare
ONEM
|
-398 M | - | - | $ 3.37 B | USA |
 |
NextGen Healthcare
NXGN
|
-2.65 M | - | - | $ 1.6 B | USA |
 |
Premier
PINC
|
17.9 M | - | - | $ 2.33 B | USA |
 |
HealthEquity
HQY
|
215 M | $ 105.41 | 1.09 % | $ 9.08 B | USA |
 |
Streamline Health Solutions
STRM
|
-10.2 M | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
-67.8 M | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
-4.44 M | - | - | $ 7.71 M | USA |
 |
10x Genomics
TXG
|
-43.5 M | $ 65.12 | 1.96 % | $ 8.12 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-148 M | - | - | $ 255 M | USA |
 |
Zhongchao
ZCMD
|
-6.31 M | $ 0.93 | 6.0 % | $ 3.18 M |  China |
 |
Omnicell
OMCL
|
2.05 M | $ 35.58 | 0.23 % | $ 1.64 B | USA |
 |
Schrödinger
SDGR
|
-103 M | $ 19.71 | 0.66 % | $ 1.45 B | USA |
 |
American Well Corporation
AMWL
|
-95.7 M | $ 11.9 | 0.93 % | $ 191 M | USA |
 |
So-Young International
SY
|
-242 M | $ 2.29 | 0.88 % | $ 178 M | China |
 |
Health Catalyst
HCAT
|
-178 M | $ 1.53 | 0.59 % | $ 107 M | USA |
 |
HealthStream
HSTM
|
18.3 M | $ 28.87 | 0.98 % | $ 867 M | USA |
 |
Evolent Health
EVH
|
-579 M | $ 4.74 | 0.96 % | $ 541 M | USA |
 |
Teladoc Health
TDOC
|
-200 M | $ 6.39 | 0.38 % | $ 1.13 B | USA |
 |
Veeva Systems
VEEV
|
909 M | $ 247.9 | 0.37 % | $ 40.6 B | USA |